UBS Group
BTMD icon

UBS Group’s Biote Corp BTMD Stock Holding History

UBS Group’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Buy
244,224
+218,496
+849% +$450K ﹤0.01% 6282
2026
Q1 		$34.7K Buy
25,728
+10,043
+64% +$20.2K ﹤0.01% 7597
2025
Q4 		$40.8K Sell
15,685
-7,658
-33% -$20.9K ﹤0.01% 7324
2025
Q3 		$70K Buy
23,343
+10,298
+79% +$36.8K ﹤0.01% 7332
2025
Q2 		$52.4K Sell
13,045
-1,023
-7% -$3.77K ﹤0.01% 7729
2025
Q1 		$46.8K Sell
14,068
-89,777
-86% -$428K ﹤0.01% 7644
2024
Q4 		$642K Buy
103,845
+96,894
+1,394% +$563K ﹤0.01% 5662
2024
Q3 		$38.8K Sell
6,951
-1,293
-16% -$8.63K ﹤0.01% 6986
2024
Q2 		$61.6K Sell
8,244
-4,756
-37% -$29.3K ﹤0.01% 6528
2024
Q1 		$75.4K Sell
13,000
-3,155
-20% -$15.8K ﹤0.01% 6338
2023
Q4 		$79.8K Buy
16,155
+8,654
+115% +$44.6K ﹤0.01% 6303
2023
Q3 		$38.4K Sell
7,501
-713
-9% -$4.2K ﹤0.01% 6464
2023
Q2 		$55.5K Buy
8,214
+7,570
+1,175% +$44.9K ﹤0.01% 6409
2023
Q1 		$3.99K Sell
644
-2,640
-80% -$11.8K ﹤0.01% 8247
2022
Q4 		$12.2K Buy
3,284
+1,259
+62% +$5.26K ﹤0.01% 8300
2022
Q3 		$9K Buy
+2,025
New +$8.6K ﹤0.01% 8563
2022
Q2 		– Sell
-2,828
Closed -$28K – 10346
2022
Q1 		$28K Buy
2,828
+422
+18% +$4.15K ﹤0.01% 7065
2021
Q4 		$24K Buy
2,406
+1,540
+178% +$15K ﹤0.01% 7621
2021
Q3 		$8K Buy
866
+376
+77% +$3.64K ﹤0.01% 8190
2021
Q2 		$5K Buy
+490
New +$4.81K ﹤0.01% 8532

Other funds holding BTMD

3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BP
Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's BTMD Position: Q2 2026 in Review

UBS Group increased its Biote Corp (BTMD) stake by 849% in Q2 2026, buying an estimated $450K and bringing the position to 244,224 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #6282.

UBS Group first reported a position in BTMD in Q2 2021 and has held it in 20 quarters since. The position peaked at $642K in Q4 2024. 72 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • UBS Group held 244,224 shares of Biote Corp worth $462K as of Q2 2026.
  • UBS Group bought 218,496 Biote Corp shares in Q2 2026, an estimated $450K.
  • Biote Corp made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6282 holding.
  • UBS Group first reported a position in Biote Corp in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's Biote Corp position peaked at $642K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.